Premium research peptides for laboratory use. All products are manufactured to the highest standards with ≥99% purity.

Retatrutide is a triple-hormone receptor agonist that interacts with three major metabolic pathways: GLP-1, GIP, and glucagon receptors. Experimental research indicates that concurrent activation of these receptors modulates energy metabolism, nutrient signaling, and glucose homeostasis.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric tissue. Research has investigated its cellular-repair, angiogenic, anti-inflammatory, and neuroprotective properties within preclinical systems.

TB-500 is a synthetic fragment of Thymosin β₄ (Tβ₄), a naturally occurring 43-amino-acid peptide involved in cell migration and actin regulation. Research has focused on its roles in cytoskeletal organization, angiogenesis, wound closure, and inflammatory signaling.

CJC-1295 is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) engineered to extend the duration and stability of native GHRH signaling. By acting on pituitary somatotrophs, it promotes physiologic pulses of growth hormone (GH) that subsequently induce hepatic insulin-like growth factor-1 (IGF-1) synthesis.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is a naturally occurring tripeptide that chelates copper(II), a trace element essential to enzymatic and reparative biochemical systems. Research indicates endogenous GHK-Cu levels decline with age, corresponding with altered collagen expression and inflammatory-gene activation.

Tesamorelin is a synthetic peptide analog of endogenous Growth Hormone–Releasing Hormone (GHRH). By binding to GHRH receptors on anterior-pituitary somatotroph cells, it triggers cyclic-AMP signaling that stimulates pulsatile growth hormone (GH) secretion and secondary insulin-like growth factor-1 (IGF-1) synthesis.

Nicotinamide adenine dinucleotide (NAD⁺) is a ubiquitous redox coenzyme investigated for its roles in cellular metabolism and signaling. NAD⁺/NADH redox cycling mediates electron transfer across glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation in preclinical systems.

Ipamorelin is a selective ghrelin-receptor (GHS-R1a) agonist designed to stimulate growth-hormone (GH) release with minimal activation of other pituitary axes in preclinical systems. In rodent and swine models, ipamorelin elicits rapid, pulse-like GH secretion from pituitary somatotrophs without meaningful elevations in prolactin, thyroid-stimulating hormone, or gonadotropins.
All products are intended for laboratory research use only. Not for human consumption, diagnostic, or therapeutic purposes. All research must be conducted in accordance with applicable local, state, and federal regulations.
You must be 21 or older to access this website
All products are for research purposes only. Not for human consumption. Please ensure you understand the intended use before proceeding.
By entering this site, you agree to our terms and confirm you are of legal age.